Camber-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ASND",
  null,
  "HUM",
  "PTCT",
  "EVH",
  "GMAB",
  "ANAB",
  "GPCR",
  "TBPH",
  "MYGN",
  "IONS",
  "TXG",
  "SPY",
  "PFE",
  "CI",
  "MLTX",
  "GMED",
  "GSK",
  "SRPT",
  "INGN",
  "VTRS",
  "ZIMV",
  "OSUR",
  "ZBH",
  null,
  "BAX",
  "BMRN",
  "BKD",
  "CON",
  "CVS",
  "DNLI"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 31
Total Value: 2751627620
Accession Number: 0001654954-25-005756
Form Type: 13F-HR
CIK: camber-capital-management-lp
Manager Name: Camber-Capital-Management-Lp

Data Enrichment

94% identified

29 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

31 positions • $2.8B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

MYRIAD GENETICS INC

MYGN|62855J104

Shares:2.4M

Value:$20.8M

% of Portfolio:0.8% ($20.8M/$2.8B)

ZimVie Inc.

ZIMV|98888T107

Shares:1.9M

Value:$20.4M

% of Portfolio:0.7% ($20.4M/$2.8B)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:441.0K

Value:$17.2M

% of Portfolio:0.6% ($17.2M/$2.8B)

Denali Therapeutics Inc.

DNLI|24823R105

Shares:1.3M

Value:$17.0M

% of Portfolio:0.6% ($17.0M/$2.8B)

ANAPTYSBIO, INC

ANAB|032724106

Shares:750.0K

Value:$13.9M

% of Portfolio:0.5% ($13.9M/$2.8B)

Theravance Biopharma, Inc.

TBPH|G8807B106

Shares:1.0M

Value:$8.9M

% of Portfolio:0.3% ($8.9M/$2.8B)

10x Genomics, Inc.

TXG|88025U109

Shares:1.0M

Value:$8.7M

% of Portfolio:0.3% ($8.7M/$2.8B)

Inogen Inc

INGN|45780L104

Shares:975.0K

Value:$7.0M

% of Portfolio:0.3% ($7.0M/$2.8B)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:300.0K

Value:$5.2M

% of Portfolio:0.2% ($5.2M/$2.8B)

ORASURE TECHNOLOGIES INC

OSUR|68554V108

Shares:900.0K

Value:$3.0M

% of Portfolio:0.1% ($3.0M/$2.8B)

GENMAB A/S

GMAB|372303206

Shares:50.0K

Value:$979.0K

% of Portfolio:0.0% ($979.0K/$2.8B)

Instrument	Shares		Other Manager	Value	% of Portfolio
MYRIAD GENETICS INC(MYGNcusip62855J104)	2.4M	QoQ -24.19% (-750.0K) YoY -69.22% (-5.3M)	All Managers (Combined)	$20.8M	0.8% ($20.8M/$2.8B)	QoQ +48944.72% (-$20.8M) YoY +12705.47% (-$20.7M)
ZimVie Inc.(ZIMVcusip98888T107)	1.9M	QoQ -30.82% (-840.0K) YoY -42.00% (-1.4M)	All Managers (Combined)	$20.4M	0.7% ($20.4M/$2.8B)	QoQ +53453.95% (-$20.3M) YoY +37886.30% (-$20.3M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	441.0K	QoQ 0.00% (+0) YoY NEW(+441.0K)	All Managers (Combined)	$17.2M	0.6% ($17.2M/$2.8B)	QoQ +72051.88% (+$17.2M) YoY NEW(+$17.2M)
Denali Therapeutics Inc.(DNLIcusip24823R105)	1.3M	QoQ -44.44% (-1.0M) YoY -16.66% (-250.0K)	All Managers (Combined)	$17.0M	0.6% ($17.0M/$2.8B)	QoQ +36959.75% (-$16.9M) YoY +55110.36% (-$17.0M)
ANAPTYSBIO, INC(ANABcusip032724106)	750.0K	QoQ -40.00% (-500.0K) YoY NEW(+750.0K)	All Managers (Combined)	$13.9M	0.5% ($13.9M/$2.8B)	QoQ +84144.71% (-$13.9M) YoY NEW(+$13.9M)
Theravance Biopharma, Inc.(TBPHcusipG8807B106)	1.0M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$8.9M	0.3% ($8.9M/$2.8B)	QoQ +94799.04% (+$8.9M) YoY +99454.06% (+$8.9M)
10x Genomics, Inc.(TXGcusip88025U109)	1.0M	QoQ 0.00% (+0) YoY NEW(+1.0M)	All Managers (Combined)	$8.7M	0.3% ($8.7M/$2.8B)	QoQ +60693.87% (+$8.7M) YoY NEW(+$8.7M)
Inogen Inc(INGNcusip45780L104)	975.0K	QoQ -51.25% (-1.0M) YoY -51.25% (-1.0M)	All Managers (Combined)	$7.0M	0.3% ($7.0M/$2.8B)	QoQ +37804.85% (-$6.9M) YoY +42971.56% (-$6.9M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	300.0K	QoQ 0.00% (+0) YoY NEW(+300.0K)	All Managers (Combined)	$5.2M	0.2% ($5.2M/$2.8B)	QoQ +63727.43% (+$5.2M) YoY NEW(+$5.2M)
ORASURE TECHNOLOGIES INC(OSURcusip68554V108)	900.0K	QoQ -78.82% (-3.4M) YoY -78.82% (-3.4M)	All Managers (Combined)	$3.0M	0.1% ($3.0M/$2.8B)	QoQ +19667.97% (-$3.0M) YoY +11503.79% (-$3.0M)
GENMAB A/S(GMABcusip372303206)	50.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$979.0K	0.0% ($979.0K/$2.8B)	QoQ +93673.94% (+$978.0K) YoY +65341.17% (+$977.5K)